Yahoo
Tokyo - Delayed Quote JPY

Kaken Pharmaceutical Co., Ltd. (4521.T)

3,800.00 +60.00 (+1.60%)
At close: 3:30:00 PM GMT+9
View in AlphaSpace Currency in JPY All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Cash Flow from Operating Activities, Indirect
-11,079,000 -11,079,000 29,780,000 2,577,000 9,253,000
Cash Flow from Investing Activities
315,000 315,000 -19,650,000 -5,854,000 -2,627,000
Cash Flow from Financing Activities
-8,841,000 -8,841,000 -5,369,000 -5,658,000 -6,990,000
Cash and Cash Equivalents, End of Period
50,705,000 50,705,000 70,085,000 65,325,000 74,260,000
Cash Flow, Supplemental
Free Cash Flow to Firm
-17,003,280.50 -17,003,280.50 22,422,090 5,846,926.40 6,468,566
Capital Expenditure, Calculated
5,423,000 5,423,000 4,392,000 2,167,000 2,206,000
Issuance of Capital Stock
0 0 7,764,000 1,000 0
Repurchase of Capital Stock
-2,343,000 -2,343,000 -5,935,000 -2,000 -1,340,000
Free Cash Flow to Cash Flow from Operating Activities
0.84 -- 0.84 0.73 0.75
3/31/2023 - 1/1/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: